XBiotech (XBIT) Competitors $2.75 -0.14 (-4.84%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$2.75 0.00 (0.00%) As of 07/15/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock XBIT vs. BNTC, GOSS, CMPS, PRTA, ALT, AURA, RNAC, CAPR, AMRN, and INBXShould you be buying XBiotech stock or one of its competitors? The main competitors of XBiotech include Benitec Biopharma (BNTC), Gossamer Bio (GOSS), COMPASS Pathways (CMPS), Prothena (PRTA), Altimmune (ALT), Aura Biosciences (AURA), Cartesian Therapeutics (RNAC), Capricor Therapeutics (CAPR), Amarin (AMRN), and Inhibrx Biosciences (INBX). These companies are all part of the "pharmaceutical products" industry. XBiotech vs. Its Competitors Benitec Biopharma Gossamer Bio COMPASS Pathways Prothena Altimmune Aura Biosciences Cartesian Therapeutics Capricor Therapeutics Amarin Inhibrx Biosciences Benitec Biopharma (NASDAQ:BNTC) and XBiotech (NASDAQ:XBIT) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership and risk. Which has better valuation and earnings, BNTC or XBIT? Benitec Biopharma is trading at a lower price-to-earnings ratio than XBiotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBenitec BiopharmaN/AN/A-$21.75M-$1.51-8.24XBiotechN/AN/A-$38.53M-$1.29-2.13 Which has more volatility and risk, BNTC or XBIT? Benitec Biopharma has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500. Comparatively, XBiotech has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500. Do insiders & institutionals hold more shares of BNTC or XBIT? 52.2% of Benitec Biopharma shares are owned by institutional investors. Comparatively, 55.7% of XBiotech shares are owned by institutional investors. 1.3% of Benitec Biopharma shares are owned by insiders. Comparatively, 30.8% of XBiotech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media favor BNTC or XBIT? In the previous week, Benitec Biopharma and Benitec Biopharma both had 2 articles in the media. XBiotech's average media sentiment score of 1.52 beat Benitec Biopharma's score of 0.47 indicating that XBiotech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Benitec Biopharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral XBiotech 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts prefer BNTC or XBIT? Benitec Biopharma currently has a consensus target price of $23.83, suggesting a potential upside of 91.59%. Given Benitec Biopharma's stronger consensus rating and higher probable upside, equities research analysts clearly believe Benitec Biopharma is more favorable than XBiotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Benitec Biopharma 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.20XBiotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is BNTC or XBIT more profitable? XBiotech's return on equity of -21.14% beat Benitec Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets Benitec BiopharmaN/A -38.26% -35.71% XBiotech N/A -21.14%-19.55% SummaryXBiotech beats Benitec Biopharma on 8 of the 13 factors compared between the two stocks. Get XBiotech News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XBIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XBIT vs. The Competition Export to ExcelMetricXBiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$88.11M$2.96B$5.61B$9.30BDividend YieldN/A2.43%4.23%4.03%P/E Ratio-2.1320.2228.5219.58Price / SalesN/A290.74426.1793.37Price / CashN/A43.1536.0257.93Price / Book0.467.568.135.54Net Income-$38.53M-$55.11M$3.24B$257.73M7 Day Performance-10.13%3.81%0.20%-0.08%1 Month Performance0.36%11.60%5.98%8.09%1 Year Performance-58.08%-2.11%26.15%13.02% XBiotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XBITXBiotech1.9166 of 5 stars$2.75-4.8%N/A-56.3%$88.11MN/A-2.13100News CoverageBNTCBenitec Biopharma1.4576 of 5 stars$13.25+3.7%$23.83+79.9%+22.0%$347.81M$80K-8.7720GOSSGossamer Bio3.7723 of 5 stars$1.53+12.5%$8.25+439.2%+22.9%$347.77M$114.70M-6.65180Analyst ForecastHigh Trading VolumeCMPSCOMPASS Pathways1.7953 of 5 stars$3.71+1.1%$17.00+358.2%-50.0%$347.11MN/A-1.86120Analyst ForecastPRTAProthena3.5804 of 5 stars$6.43+0.5%$31.50+389.9%-72.5%$346.11M$137.94M-3.09130ALTAltimmune2.1939 of 5 stars$4.26+2.9%$18.20+327.2%-47.1%$345.53M$20K-3.3850AURAAura Biosciences2.5705 of 5 stars$6.75+5.5%$22.00+225.9%-27.0%$339.32MN/A-3.5550Positive NewsRNACCartesian Therapeutics2.2259 of 5 stars$13.06-2.0%$40.00+206.3%-24.2%$338.91M$38.91M-0.2564CAPRCapricor Therapeutics2.3695 of 5 stars$7.39-3.3%$22.56+205.2%+54.1%$337.58M$22.27M-5.20101Analyst ForecastAMRNAmarin0.2903 of 5 stars$16.10-4.9%$12.00-25.5%+5.1%$333.43M$228.61M-4.42360Positive NewsINBXInhibrx Biosciences2.4497 of 5 stars$22.96+5.5%N/A+65.7%$332.46M$200K0.20166 Related Companies and Tools Related Companies BNTC Competitors GOSS Competitors CMPS Competitors PRTA Competitors ALT Competitors AURA Competitors RNAC Competitors CAPR Competitors AMRN Competitors INBX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XBIT) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XBiotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share XBiotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XBIT Stock Alerts